Open Beta
TREN
MetriLume
TREN

US marketsARDX

SEC-sourced researchBeta

ARDX

ARDELYX, INC.

Company comparison ↗

Data passport

CIK
0001437402
Exchange
Nasdaq
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Aug 25, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2023: 124,456,000.0000 USD; December 2024: 333,615,000.0000 USD; December 2025: 407,320,000.0000 USD407.3M USD0 USD0December 2023December 2024December 2025
ARDX · Exact amounts and source periods · USD
Period endRevenueFiling date
December 2023124,456,000.0000Feb 19, 2026
December 2024333,615,000.0000Feb 19, 2026
December 2025407,320,000.0000Feb 19, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025407,320,000.0000-61,599,000.0000-42,483,000.0000501,604,000.0000334,655,000.0000Feb 19, 2026
December 2024333,615,000.0000-39,136,000.0000-44,809,000.0000435,754,000.0000262,465,000.0000Feb 19, 2026
December 2023124,456,000.0000-66,067,000.0000-89,717,000.0000——Feb 19, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

51/100
Profitability20
Growth72
Balance sheet33
Cash generation29
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$407.32MJan 1, 2025 – Dec 31, 2025Feb 19, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$333.62MJan 1, 2024 – Dec 31, 2024Feb 19, 202610-K
Net incomeNetIncomeLoss-$61.6MJan 1, 2025 – Dec 31, 2025Feb 19, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$42.48MJan 1, 2025 – Dec 31, 2025Feb 19, 202610-K
Total assetsAssets$501.6MDec 31, 2025Feb 19, 202610-K
Total liabilitiesLiabilities$334.66MDec 31, 2025Feb 19, 202610-K

New filings

Explore methodology ↗